Noteworthy, FFDZ dramatically increased serum SOD and GPx levels while reducing liver function indices and MDA levels in NAFLD mice, thereby repairing the liver damage induced by lipid metabolism disorders, which is consistent with previous research findings (Huang et al., 2024). The gene discussed is SOD1; the disease is metabolic dysfunction-associated steatotic liver disease.